We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+9.77%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$203M
AUM Growth
+$18.8M
Cap. Flow
+$773K
Cap. Flow %
0.38%
Top 10 Hldgs %
50.6%
Holding
95
New
11
Increased
22
Reduced
17
Closed
12

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$2.05M
2
AMGN icon
Amgen
AMGN
+$966K
3
TDOC icon
Teladoc Health
TDOC
+$933K
4
GDX icon
VanEck Gold Miners ETF
GDX
+$739K
5
PRTA icon
Prothena Corp
PRTA
+$684K

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.52M
2
XNCR icon
Xencor
XNCR
+$608K
3
IMGN
Immunogen Inc
IMGN
+$415K
4
ORCL icon
Oracle
ORCL
+$372K
5
BUR icon
Burford Capital
BUR
+$263K

Sector Composition

Rank Sector Weight
1 Healthcare 29.96%
2 Technology 19.82%
3 Communication Services 7.67%
4 Consumer Discretionary 3.77%
5 Financials 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNSR icon
51
LENSAR
LNSR
$61.5M
$809K 0.4%
238,234
-2,300
-1% -$9.46K
TDOC icon
52
Teladoc Health
TDOC
$1.22B
$776K 0.38%
+51,400
New +$933K
PYPL icon
53
PayPal
PYPL
$48.9B
$737K 0.36%
11,000
– –
PAAS icon
54
Pan American Silver
PAAS
$18.2B
$679K 0.33%
45,000
– –
WOLF icon
55
Wolfspeed
WOLF
$1.23B
$608K 0.3%
20,600
+13,100
+175% +$395K
SNY icon
56
Sanofi
SNY
$103B
$535K 0.26%
11,000
– –
PFE icon
57
Pfizer
PFE
$143B
$534K 0.26%
19,250
-2,250
-10% -$62.4K
GDXJ icon
58
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
$531K 0.26%
13,700
– –
SPOT icon
59
Spotify
SPOT
$103B
$528K 0.26%
2,000
– –
EEM icon
60
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$514K 0.25%
12,500
– –
LRCX icon
61
Lam Research
LRCX
$367B
$486K 0.24%
5,000
– –
YETI icon
62
Yeti Holdings
YETI
$3.71B
$482K 0.24%
12,500
+2,500
+25% +$106K
MU icon
63
PUT
Micron Technology
MU
$930B
$472K 0.23%
+4,000
New +$362K
C icon
64
Citigroup
C
$222B
$458K 0.23%
7,250
– –
IOT icon
65
Samsara
IOT
$21.7B
$378K 0.19%
+10,000
New +$340K
EVO icon
66
Evotec
EVO
$679M
$374K 0.18%
47,797
– –
TEVA icon
67
CALL
Teva Pharmaceuticals
TEVA
$40.8B
$317K 0.16%
+22,500
New +$284K
PANW icon
68
Palo Alto Networks
PANW
$270B
$284K 0.14%
+2,000
New +$315K
VRDN icon
69
Viridian Therapeutics
VRDN
$2.09B
$254K 0.13%
14,500
+5,000
+53% +$96.9K
JNJ icon
70
Johnson & Johnson
JNJ
$618B
$237K 0.12%
1,500
– –
NOK icon
71
Nokia
NOK
$51B
$177K 0.09%
50,000
– –
LCTX icon
72
Lineage Cell Therapeutics
LCTX
$269M
$159K 0.08%
107,751
+13,000
+14% +$14.7K
SPYM
73
CALL
State Street SPDR Portfolio S&P 500 ETF
SPYM
$161B
$154K 0.08%
+2,500
New +$146K
BIDU icon
74
CALL
Baidu
BIDU
$37.7B
$105K 0.05%
1,000
-6,500
-87% -$692K
ARQ icon
75
Arq
ARQ
$84.6M
$104K 0.05%
16,000
+2,504
+19% +$9.34K
1 2
3
4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, DCF Advisers held 95 positions worth $203M, up 10% from $184M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

DCF Advisers's Q1 2024 filing shows 11 new, 22 increased, 17 reduced and 12 closed positions. Its largest new stake was Baidu: 19,250 shares worth $2.03M. The largest sale was Regeneron Pharmaceuticals, an estimated $1.52M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 32% a quarter earlier, followed by Technology and Communication Services.

  • DCF Advisers's largest Q1 2024 buy was Baidu: 19,250 shares worth $2.03M.
  • DCF Advisers added most to Amgen in Q1 2024, an estimated $966K increase.
  • DCF Advisers's biggest Q1 2024 reduction was Regeneron Pharmaceuticals, cutting an estimated $1.52M.
  • DCF Advisers fully exited Immunogen Inc in Q1 2024, selling an estimated $415K.
  • DCF Advisers's ten largest holdings make up 51% of its $203M portfolio in Q1 2024.
  • DCF Advisers opened 11 new positions and closed 12 in Q1 2024.
  • DCF Advisers's portfolio value rose 10% quarter-over-quarter to $203M.

Based on DCF Advisers's 13F filing for Q1 2024, filed 15 May 2024.